Lactoferrin Inhibits Enterovirus 71 Infection of Human Embryonal Rhabdomyosarcoma Cells In Vitro
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Enterovirus 71 (EV71), the newest member of Enterovirudae, is notable for its etiological role in epidemics of severe neurological diseases in children. It appears to be emerging as an important virulent neurotropic enterovirus in the upcoming era of poliomyelitis eradication, whereas no effective vaccine or antiviral agents are available at this moment. Human and bovine lactoferrins, iron-binding proteins belonging to the nonimmune defense system, were assayed in vitro to assess their inhibiting capacity on the cytopathic effect of EV71 on human embryonal rhabdomyosarcoma (RD) cells. Both bovine and human lactoferrins were found to be potent inhibitors of EV71 infection (mean IC(50), 10.5-24.5 microg/mL and 103.3-185.0 microg/mL, respectively). Lactoferrin probably exerts its effect at the level of viral adsorption, since the ongoing infection could not be further inhibited after the EV71 penetrated RD cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment
Yamauchi, K., Tomita, M., Giehl, T. J., & Ellison, R. T. (1993) · Infection and Immunity · doi:10.1128/iai.61.2.719-728.1993 · Cited by 500 · cited 1×
“An antibacterial domain has been identified in the lactoferrin polypeptide backbone [17].”
BackgroundHarmsen, M. C., Swart, P. J., Bethune, M.-P. D., Pauwels, R., Clercq, E. D., The, T. B., & Meijer, D. K. F. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/172.2.380 · Cited by 379
Enterovirus infections: diagnosis and treatment.
SAWYER, M. H. (1999) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199912000-00002 · Cited by 127
Cited by
Bovine whey proteins – Overview on their main biological properties
Madureira, A. R., Pereira, C. I., Gomes, A. M. P., Pintado, M. E., & Xavier Malcata, F. (2007) · Food Research International · doi:10.1016/j.foodres.2007.07.005 · Cited by 600
Lactoferrin: Structure, function, denaturation and digestion
Wang, B., Timilsena, Y. P., Blanch, E., & Adhikari, B. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2017.1381583 · Cited by 514
Antimicrobial properties of lactoferrin
JENSSEN, H., & HANCOCK, R. (2009) · Biochimie · doi:10.1016/j.biochi.2008.05.015 · Cited by 509
Lactoferrin a multiple bioactive protein: an overview
García-Montoya, I. A., Cendón, T. S., Arévalo-Gallegos, S., & Rascón-Cruz, Q. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.06.018 · Cited by 473
Lactoferrin as a natural immune modulator
Actor, J., Hwang, S.-A., & Kruzel, M. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788453202 · Cited by 455
“Finally, numerous trials have examined lactoferrin to modulate responses to cancer antigens, for use in prophylactic or therapeutic treatment [175–179].”
Background
Metadata
- Authors
- Lin, T., Chu, C., & Chiu, C.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-10-15
- Volume
- 186
- Issue
- 8
- Pages
- 1161-1164
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2160298781
- Cited by
- 103
- References
- 3
- FWCI
- 2.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.